Chromogranin A (CgA) and the Ki-67 proliferation index are considered as important biochemical and pathological markers for clinical behaviour of gastroenteropancreatic neuroendocrine tumors (GEP NETs), respectively. This evidence concerns the gene CHGA and digestive system neuroendocrine tumor, grade 1/2.